Nevro Corp
Nevro Corp., a medical device company, engages in the provision of products for patients suffering from chronic pain in the United States and internationally. The company provides HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic back and leg pain through paresthesia-free 10 kHz therapy, as well a… Read more
Nevro Corp (NVRO) - Total Liabilities
Latest total liabilities as of December 2024: $322.83 Million USD
Based on the latest financial reports, Nevro Corp (NVRO) has total liabilities worth $322.83 Million USD as of December 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Nevro Corp - Total Liabilities Trend (2012–2024)
This chart illustrates how Nevro Corp's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Nevro Corp Competitors by Total Liabilities
The table below lists competitors of Nevro Corp ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Surya Semesta Internusa Tbk
JK:SSIA
|
Indonesia | Rp3.57 Trillion |
|
Addnode Group AB Series B
LSE:0GMG
|
UK | Skr7.07 Billion |
|
Seoul Food Ind Co Ltd
KO:004415
|
Korea | ₩46.52 Billion |
|
Coremax Corp
TW:4739
|
Taiwan | NT$5.86 Billion |
|
BingEx Ltd
NASDAQ:FLX
|
USA | $432.60 Million |
|
Jiangnan Yifan Motor Co.Ltd
SHE:301023
|
China | CN¥73.95 Million |
|
Zhejiang Aishida Electric Co Ltd
SHE:002403
|
China | CN¥3.18 Billion |
|
Soyea Technology Co Ltd
SHE:000909
|
China | CN¥1.30 Billion |
Liability Composition Analysis (2012–2024)
This chart breaks down Nevro Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.62 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.40 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.58 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Nevro Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Nevro Corp (2012–2024)
The table below shows the annual total liabilities of Nevro Corp from 2012 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $322.83 Million | -5.76% |
| 2023-12-31 | $342.57 Million | +22.99% |
| 2022-12-31 | $278.53 Million | +2.81% |
| 2021-12-31 | $270.93 Million | -32.43% |
| 2020-12-31 | $400.97 Million | +58.30% |
| 2019-12-31 | $253.29 Million | +16.39% |
| 2018-12-31 | $217.63 Million | +6.22% |
| 2017-12-31 | $204.88 Million | +12.85% |
| 2016-12-31 | $181.55 Million | +220.81% |
| 2015-12-31 | $56.59 Million | +86.00% |
| 2014-12-31 | $30.43 Million | +281.95% |
| 2013-12-31 | $7.97 Million | +44.92% |
| 2012-12-31 | $5.50 Million | -- |